EUVIMEDEUVIMED entdecken
Crossref

Single-Cell Analysis Reclassifies Eczematous Mycosis Fungoides as Severe Atopic Dermatitis 2259810

Jung-Ho Lee, Hyun Je Kim, Sung Ha Lim, Jiyoung Ahn

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.789 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Jung-Ho Lee und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mycosis fungoides (MF), the prevalent subtype of cutaneous T-cell lymphoma (CTCL), primarily affects the skin and progresses systemically over time. Early-stage MF diagnosis relies on immunohistochemistry, T cell receptor (TCR) gene rearrangement testing, and clinical evaluation. However, in the clinic settings, we observe eczematous MF (eMF) patients who meet early-stage MF diagnostic criteria but exhibit phenotypes resembling atopic dermatitis (AD), and refractory to dupilumab. This study investigates the molecular characteristics of eMF in comparison to AD and classic MF, providing insights into its distinct pathophysiology and potential therapeutic implications.

Methods

Skin biopsies were collected from seven AD patients and eleven eMF patients. Paired single-cell RNA sequencing (scRNA-seq) and single-cell TCR sequencing (scTCR-seq) were conducted to evaluate transcriptional profiles and T-cell clonality. Publicly available MF and AD scRNA-seq data were used for comparative analysis. In addition, spatial transcriptomic profiling was performed to validate.

Results

Comparative transcriptomic analysis showed that the molecular profiles of T cells in eMF resembled those in AD rather than in conventional MF. Furthermore, in eMF, we observed oligoclonal T-cell expansions, which were not found in conventional MF both in scRNA-seq and spatial transcriptomic data. These expanded cells were predominantly Th22 cells, identified as the primary producers of IL-13, a key cytokine in AD pathophysiology. Conclusion eMF diagnostic phenotype resembles conventional MF, and AD primarily due to the hyperproliferation of Th22 cells and their expression of IL-13. In this context, this mechanism underscores the superior efficacy of Upadacitinib, which could target Th22 differentiation, over Dupilumab. As a result, our findings indicate that eMF is not cancer, but a Th22-mediated AD endotype. Funding Source n/a Topic Categories Immune Mechanisms of Human Disease (HUM)

Zitieren

APA

Lee, J., Kim, H. J., Lim, S. H., & Ahn, J. (2026). Single-Cell Analysis Reclassifies Eczematous Mycosis Fungoides as Severe Atopic Dermatitis 2259810. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.789

Vancouver

Lee J, Kim HJ, Lim SH, Ahn J. Single-Cell Analysis Reclassifies Eczematous Mycosis Fungoides as Severe Atopic Dermatitis 2259810. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.789

BibTeX
@article{Lee2026,
  author = {Lee, Jung-Ho and Kim, Hyun Je and Lim, Sung Ha and Ahn, Jiyoung},
  title = {Single-Cell Analysis Reclassifies Eczematous Mycosis Fungoides as Severe Atopic Dermatitis 2259810},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.789}
}
Kostenlos starten →